{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T07:53:35Z","timestamp":1780732415251,"version":"3.54.1"},"reference-count":28,"publisher":"Hindawi Limited","issue":"6","license":[{"start":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T00:00:00Z","timestamp":1472601600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T00:00:00Z","timestamp":1472601600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1111\/jcpt.12439","type":"journal-article","created":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T16:42:27Z","timestamp":1472661747000},"page":"657-661","source":"Crossref","is-referenced-by-count":30,"title":["Oral nifedipine vs. intravenous labetalol for treatment of pregnancy-induced severe pre-eclampsia"],"prefix":"10.1155","volume":"41","author":[{"given":"D.-D.","family":"Shi","sequence":"first","affiliation":[{"name":"Cangzhou Central Hospital; Cangzhou City Hebei Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.-Z.","family":"Yang","sequence":"additional","affiliation":[{"name":"Cangzhou Central Hospital; Cangzhou City Hebei Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Zhou","sequence":"additional","affiliation":[{"name":"Cangzhou Central Hospital; Cangzhou City Hebei Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Wang","sequence":"additional","affiliation":[{"name":"Cangzhou Central Hospital; Cangzhou City Hebei Province China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2016,8,31]]},"reference":[{"key":"10.1111\/jcpt.12439-BIB0001|jcpt12439-cit-0001","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejogrb.2015.02.002","article-title":"Ketanserin versus dihydralazine for the treatment of severe hypertension in early-onset preeclampsia: a double blind randomized controlled trial","volume":"189","author":"Bijvank","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1111\/jcpt.12439-BIB0002|jcpt12439-cit-0002","first-page":"CD002252","article-title":"Antihypertensive drug therapy for mild to moderate hypertension during pregnancy","volume":"2","author":"Abalos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/jcpt.12439-BIB0003|jcpt12439-cit-0003","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1701-2163(16)32776-1","article-title":"Hypertension Guideline C, Strategic Training Initiative in Research in the Reproductive Health Sciences S. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy","volume":"30","author":"Magee","year":"2008","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1111\/jcpt.12439-BIB0004|jcpt12439-cit-0004","first-page":"1402","article-title":"Pre-eclampsia, eclampsia, and hypertension","volume":"2008","author":"Duley","year":"2008","journal-title":"BMJ Clin Evid"},{"key":"10.1111\/jcpt.12439-BIB0005|jcpt12439-cit-0005","first-page":"970","article-title":"Hemodynamic changes associated with intravenous infusion of the calcium antagonist verapamil in the treatment of severe gestational proteinuric hypertension","volume":"75","author":"Belfort","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1111\/jcpt.12439-BIB0006|jcpt12439-cit-0006","first-page":"CD001449","article-title":"Drugs for treatment of very high blood pressure during pregnancy","volume":"7","author":"Duley","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/jcpt.12439-BIB0007|jcpt12439-cit-0007","first-page":"331","article-title":"Nifedipine in the treatment of severe preeclampsia","volume":"77","author":"Fenakel","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1111\/jcpt.12439-BIB0008|jcpt12439-cit-0008","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00404-012-2371-x","article-title":"Nifedipine versus labetalol in the treatment of hypertensive disorders of pregnancy","volume":"286","author":"Giannubilo","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1111\/jcpt.12439-BIB0009|jcpt12439-cit-0009","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/00006250-199404000-00024","article-title":"Nifedipine and its indications in obstetrics and gynecology","volume":"83","author":"Childress","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1111\/jcpt.12439-BIB0010|jcpt12439-cit-0010","doi-asserted-by":"crossref","first-page":"714","DOI":"10.7326\/0003-4819-105-5-714","article-title":"Nifedipine in myocardial ischemia, systemic hypertension, and other cardiovascular disorders","volume":"105","author":"Ferlinz","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1111\/jcpt.12439-BIB0011|jcpt12439-cit-0011","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/0002-9378(90)91011-Z","article-title":"The use of nifedipine during the postpartum period in patients with severe preeclampsia","volume":"162","author":"Barton","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/jcpt.12439-BIB0012|jcpt12439-cit-0012","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1053\/j.semperi.2015.08.011","article-title":"A review of oral labetalol and nifedipine in mild to moderate hypertension in pregnancy","volume":"39","author":"Clark","year":"2015","journal-title":"Semin Perinatol"},{"key":"10.1111\/jcpt.12439-BIB0013|jcpt12439-cit-0013","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2165\/00002018-200124060-00004","article-title":"Treating hypertension in women of child-bearing age and during pregnancy","volume":"24","author":"Magee","year":"2001","journal-title":"Drug Saf"},{"key":"10.1111\/jcpt.12439-BIB0014|jcpt12439-cit-0014","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1365-2125.2011.04002.x","article-title":"How to manage hypertension in pregnancy effectively","volume":"72","author":"Magee","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/jcpt.12439-BIB0015|jcpt12439-cit-0015","first-page":"CD002252","article-title":"Antihypertensive drug therapy for mild to moderate hypertension during pregnancy","author":"Abalos","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/jcpt.12439-BIB0016|jcpt12439-cit-0016","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1111\/jcpt.12439-BIB0017|jcpt12439-cit-0017","first-page":"CD001449","article-title":"Drugs for treatment of very high blood pressure during pregnancy","author":"Duley","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/jcpt.12439-BIB0018|jcpt12439-cit-0018","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1471-0528.2011.03151.x","article-title":"Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial","volume":"119","author":"Raheem","year":"2012","journal-title":"BJOG"},{"key":"10.1111\/jcpt.12439-BIB0019|jcpt12439-cit-0019","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijcard.2014.10.111","article-title":"Oral nifedipine versus intravenous labetalol for the treatment of severe hypertension in pregnancy","volume":"178","author":"Shi","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1111\/jcpt.12439-BIB0020|jcpt12439-cit-0020","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/bmj.327.7421.955","article-title":"Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis","volume":"327","author":"Magee","year":"2003","journal-title":"BMJ"},{"key":"10.1111\/jcpt.12439-BIB0021|jcpt12439-cit-0021","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1034\/j.1600-0412.2002.810105.x","article-title":"Nifedipine or hydralazine as a first-line agent to control hypertension in severe preeclampsia","volume":"81","author":"Aali","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1111\/jcpt.12439-BIB0022|jcpt12439-cit-0022","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0272-6386(12)80087-4","article-title":"Prevention and treatment of pregnancy-associated hypertension: what have we learned in the last 10 years?","volume":"18","author":"Remuzzi","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/jcpt.12439-BIB0023|jcpt12439-cit-0023","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1479-828X.2000.tb01137.x","article-title":"The detection, investigation and management of hypertension in pregnancy: full consensus statement","volume":"40","author":"Brown","year":"2000","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1111\/jcpt.12439-BIB0024|jcpt12439-cit-0024","first-page":"1245","article-title":"Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy","volume":"157","author":"Rey","year":"1997","journal-title":"CMAJ"},{"key":"10.1111\/jcpt.12439-BIB0025|jcpt12439-cit-0025","first-page":"181","article-title":"Diagnosis and management of gestational hypertension and preeclampsia","volume":"102","author":"Sibai","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1111\/jcpt.12439-BIB0026|jcpt12439-cit-0026","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.preghy.2013.08.001","article-title":"Hydralazine vs labetalol for the treatment of severe hypertensive disorders of pregnancy. A randomized, controlled trial","volume":"4","author":"Delgado De Pasquale","year":"2014","journal-title":"Pregnancy Hypertens"},{"key":"10.1111\/jcpt.12439-BIB0027|jcpt12439-cit-0027","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0002-9378(99)70314-5","article-title":"A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy","volume":"181","author":"Vermillion","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/jcpt.12439-BIB0028|jcpt12439-cit-0028","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/1471-0528.13463","article-title":"Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis","volume":"123","author":"Shekhar","year":"2016","journal-title":"BJOG"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12439","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12439","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12439\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:02:11Z","timestamp":1671818531000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,31]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12439","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8,31]]}}}